These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3304210)

  • 1. Overdose toxicity studies versus threshold: elements of biology must be incorporated into risk assessment.
    Hildebrandt AG
    Arch Toxicol; 1987; 60(1-3):217-23. PubMed ID: 3304210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans.
    Sahota T; Danhof M; Della Pasqua O
    Mutagenesis; 2016 May; 31(3):359-74. PubMed ID: 26970519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of efficacy, toxicity and quality of care in long-term drug treatment.
    Dollery CT
    Ciba Found Symp; 1976; (44):73-88. PubMed ID: 829769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and practice of prodrug kinetics.
    Notari RE
    Methods Enzymol; 1985; 112():309-23. PubMed ID: 4046852
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic considerations in the design of toxicology experiments.
    Darby TD
    Clin Toxicol; 1978 Feb; 12(2):229-38. PubMed ID: 648118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.
    Terry C; Rasoulpour RJ; Knowles S; Billington R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):301-17. PubMed ID: 25584438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico methods to predict drug toxicity.
    Roncaglioni A; Toropov AA; Toropova AP; Benfenati E
    Curr Opin Pharmacol; 2013 Oct; 13(5):802-6. PubMed ID: 23797035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE PROBLEM OF DRUG TOXICITY.
    DUNLOP D
    Practitioner; 1965 Jan; 194():5-8. PubMed ID: 14259693
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug availability to noneliminating tissues and sites of action following an intravenous dose.
    Cutler DJ
    J Pharm Sci; 1986 Dec; 75(12):1141-4. PubMed ID: 3559922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoisomers and drug toxicity. The value of single stereoisomer therapy.
    Scott AK
    Drug Saf; 1993 Feb; 8(2):149-59. PubMed ID: 8452656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?
    Horii I
    J Toxicol Sci; 2016; 41(Special):SP49-SP67. PubMed ID: 28250284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADVERSE DRUG REACTION REPORTING AND THE RELATED ESTABLISHMENT OF A REGISTRY OF TISSUE REACTIONS TO DRUGS.
    WESTON JK
    Med Ann Dist Columbia; 1965 Aug; 34():380-2. PubMed ID: 14338452
    [No Abstract]   [Full Text] [Related]  

  • 19. Present attitudes of governmental drug regulatory agencies.
    Noel PR
    Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormesis [biological effects of low-level exposure (B.E.L.L.E.)] and dermatology.
    Thong HY; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):329-41. PubMed ID: 18058307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.